A comparison of visual analog scale and categorical ratings in assessing the patient's estimate of sleep quality

Sleep and Sleep Disorders: A Neuropsychopharmacological Approach

Volumn , Issue , 2006, Pages 220-224

  Zisapel, Nava ^a   Tarrasch, Ricardo ^a   Laudon, Moshe ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b NEURIM PHARMACEUTICALS LTD   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856826593     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-27682-3_25     Document Type: Chapter

References (17)

1. Pedis ML, Giles DE, Mendelson WB et al. Psychophysiological insomnia: The behavioural model and a neurocognitive perspecdve. J Sleep Res 1997; 6:179-88.
2. Schneider-Helmert D, Kumar A. Sleep, its subjective perception, and daytime performance in insomniacs with a pattern of alpha sleep. Biol Psychiatry 1995; 37:99-105.
3. Costa Silva JA, Chase M, Sartorius N et al. Special report from a symposium held by the World Health Organization and the World Federation of Sleep Research Societies: An overview of insomnias and related disorders-recognition, epidemiology, and rational management. Sleep 1996; 19:412-6.
4. Parrott AC, Hindmarch I. Factor analysis of a sleep evaluation questionnaire. Psychol Med 1978; 8:325-9.
5. Parrott AC, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - A review. Psychopharmacology 1980; 71:173-9.
6. Felson DT, Anderson JJ, Boers M et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993; 36:729-40.
7. Spielman A, Yang C, Glovinsky P. Assessment techniques for insomnia. In: Kryger M, Roth T, Dement W, eds. Principles and practice of sleep medicine. Philadelphia: Saunders Co., 2000:1239-1250.
8. Roth T, Roehrs T, Vogel G. Zolpidem in the treatment of transient insomnia: A double-blind, randomized comparison with placebo. Sleep 1995; 18:246-51.
9. Walsh JK, Roth T, Randazzo A et al. Eight weeks of nonnighdy use of Zolpidem for primary insomnia. Sleep 2000; 23:1087-96.
10. Riedel BW, Lichstein KL. Objective sleep measures and subjective sleep satisfaaion: How do older adults with insomnia define a good nights sleep? Psychol Aging 1998; 13:159-63.
11. Morin CM, Mimeault V, Gagne A. Nonpharmacological treatment of late-life insomnia. J Psychosom Res 1999; 46:103-16.
12. Zisapel N, Laudon M. Subjective Assessment of the Effects of CNS-Active Drugs on Sleep by The Leeds Sleep Evaluation Questionnaire: A Review. Human Neuropsychopharmacol Clin Exp 2002; In Press.
13. Anderson JJ, ChernofF MC. Sensitivity to change of rheumatoid arthritis clinical trial outcome measures. J Rheumatol 1993; 20:535-7.
14. Zar J. Biostatistical analysis. New Jersey: Prentice Hall, 1984; 156.
15. Skovlund E, Flaten O. Response measures in the acute treatment of migraine. Cephalalgia 1995; 15:519-22:discussion 450-1.
16. Lines C, Visser W, Vandormeal K et al. Rizatripan 5mg versus sumatripan 50mg in the acute treatment of migraine (abstract). Headache 1997; 37:319-320.
17. Hamalainen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: A randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology 1997; 48:1100-3.